Cytosorbents (CTSO) Tops Q1 EPS by 2c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $4.93 million versus the consensus estimate of $4.82 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
• Knowles (KN) Tops Q2 EPS by 2c, Offers Guidance
• United Bancorp (UBCP) Reports Q2 EPS of $0.36